Abdelhadi Boussena | Molecular Biology | Best Researcher Award

Posted on by chemical Scientist

Dr. Abdelhadi Boussena | Molecular Biology | Best Researcher Award

chlef university , Algeria.

πŸ”¬ Short BiographyΒ πŸŒΏπŸ’ŠπŸ“š

Abdelhadi Boussena πŸŽ“ is a dedicated microbiologist 🧫 from Algeria πŸ‡©πŸ‡Ώ with a passion for scientific research and academic development. Holding a Ph.D. in Microbiology from Abdelhamid Ibn Badis University, Mostaganem, he has built his expertise in parasitology, microbial ecology, and antibacterial properties of medicinal plants 🌿. His academic path reflects consistent excellence, starting with a Bachelor’s and Master’s in Microbiology from Hassiba Ben Bouali University, Chlef. Professionally, he has served as a pharmacy assistant and contributed to the academic community through student supervision and course instruction πŸ§‘β€πŸ«. Boussena has published and presented multiple research studies focusing on antibacterial and antioxidant properties of natural extracts πŸ§ͺ. Fluent in Arabic and competent in French πŸ‡«πŸ‡· and English πŸ‡¬πŸ‡§, he combines solid communication skills with a calm and problem-solving approach. His ambition is to continue expanding knowledge in microbiology and contribute to global scientific advancement 🌍.

PROFILEΒ 

ORCIDΒ 

πŸ” Summary of Suitability:

Dr. Abdelhadi Boussena demonstrates a clear and consistent dedication to microbiological research, particularly in the exploration of bioactive compounds from medicinal plants 🌿. His work targets globally significant challenges such as antibiotic resistance, biofilm inhibition, and natural antioxidant discovery, aligning closely with public health priorities and sustainable scientific innovation 🌍. Through his publications, participation in international symposia, and academic involvement in student mentorship and teaching πŸ§‘β€πŸ«, he exemplifies qualities of a committed and impactful researcher.

πŸ“˜ Education & Experience

Education:

  • πŸ“š Ph.D. in Microbiology – Abdelhamid Ibn Badis University, Mostaganem (2019)

  • πŸ“˜ Master of Science in Microbiology – Hassiba Ben Bouali University, Chlef

  • 🧬 Bachelor of Science in Parasitology and Microbiology – Hassiba Ben Bouali University, Chlef

Experience:

  • πŸ’Š Pharmacy Assistant – Chlef, Algeria (2016–2017)

  • πŸ§‘β€πŸ« Teaching in microbial ecology & systematics (2022)

  • πŸ§‘β€πŸŽ“ Co-supervised Master’s students (2019–2022)

  • 🌿 Researcher in medicinal plant valorization

Professional Development πŸš€πŸ“–

Abdelhadi Boussena’s career reflects a strong commitment to continuous professional development and academic excellence πŸ“–. He actively engages in research focused on microbiological applications of medicinal plants 🌱, exploring their antibacterial and antioxidant properties. His teaching role includes guiding students in microbial ecology and systematics 🧫, demonstrating both pedagogical skills and scientific depth. Boussena has presented at multiple national and international symposia 🎀, broadening his academic network and knowledge base. He has authored peer-reviewed articles on topics such as the phytochemical properties of Ephedra alata and Haloxylon scoparium πŸ“„. His work aims to combat multidrug-resistant pathogens, contributing to public health and environmental sustainability 🧬🌍. Through collaboration, publications, and supervision, he demonstrates leadership and mentorship. His ability to adapt to new scientific methods and share knowledge makes him an asset in microbiology and natural product research πŸ’‘.

Research Focus πŸ”πŸ€–

Dr. Abdelhadi Boussena’s research centers on the microbiological evaluation of medicinal plants 🌿 for their therapeutic potential against resistant bacterial strains 🦠. His work integrates phytochemical screening, antibacterial and antioxidant assays to identify bioactive compounds from Algerian flora such as Ephedra alata and Haloxylon scoparium 🌡. This research plays a pivotal role in addressing global health concerns related to antibiotic resistance 🧫. He is particularly interested in nosocomial pathogens and biofilm-forming bacteria like Staphylococcus aureus and Pseudomonas aeruginosa πŸ§ͺ. His methods include agar dilution and phenolic content analysis to evaluate extract potency. Boussena also explores the ecological and sustainable development implications of his findings 🌎. His work contributes to green chemistry and integrative medicine, positioning him at the intersection of environmental microbiology, pharmacognosy, and public health πŸ’Š. Through experimentation and collaboration, his ultimate goal is to harness nature’s pharmacy for modern therapeutic solutions.

Awards and Honors πŸ†πŸŽ–οΈ

  • πŸ† Participant – First National Seminar on Nutrition and Health

  • πŸ₯‡ Presenter – 1st International Symposium on Environment & Sustainable Development

  • πŸ§ͺ Speaker – National Seminar on Biodiversity of Fauna and Flora in Algeria (2022)

  • πŸ“„ Published – International Journal of Human Settlements (Antibiofilm Study)

  • πŸ“˜ Published – Journal of Applied Biological Sciences (Phytochemical Analysis)

Publications & Citations πŸ“š

πŸ“˜ β€œEvaluation of the antioxidant activity of the hydro-methanolic extract of Ephedra alata (Ephedraceae)” – Published: 2020 πŸ“… | Citation info: Not listed πŸ“‰ | πŸ§ͺ🌿🧫

πŸ“˜ β€œActivitΓ© antibactΓ©rienne des deux extraits d’Ephedra alata sur une bactΓ©rie entΓ©rique Γ  Gram nΓ©gatif…” – Published: 2021 πŸ“… | Citation info: Not listed πŸ“‰ | πŸ¦ πŸ”¬πŸŒ±

πŸ“˜ β€œActivitΓ©s antibactΓ©riennes et antibiofilms des souches de lactobacilles vis-Γ -vis Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis, B. cereus” – Published in International Journal of Human Settlements, Year: Unknown πŸ“… | Citation info: Not listed πŸ“‰ | 🧫πŸ§ͺ🧬

πŸ“˜ β€œPhytochemical screening, phenolic content and antioxidant activity of Haloxylon scoparium” – Published: 2022 πŸ“… | Citation info: Not listed πŸ“‰ | 🌿πŸ§ͺ🧬

πŸ“˜ β€œScreening of phytochemicals, evaluation of phenolic content, antibacterial and antioxidant activities of Ephedra alata from Algerian Sahara” – Published: 2022 πŸ“… | Citation info: Not listed πŸ“‰ | 🌡πŸ§ͺπŸ”¬

πŸ“˜ β€œUse of Haloxylon scoparium Against Multidrug-Resistant Bacteria from Urinary Tract Infections” – Published: Unknown πŸ“… | Citation info: Not listed πŸ“‰ | πŸ’ŠπŸ¦ πŸŒ±

πŸ” Conclusion:

Dr. Abdelhadi Boussena’s research is both scientifically relevant and socially impactful, addressing critical issues in antimicrobial resistance through eco-conscious methods. His proactive involvement in academia and sustained research output make him highly suitable for recognition through a Best Researcher Award. His work bridges microbiology and pharmacognosy, fostering innovation and contributing to the global effort for sustainable and effective health solutions. πŸ†

 

 

 

Waldo Ullah | Biochemical Pharmacology | Best Researcher Award

Posted on by chemical Scientist

Prof. Dr. Waldo Ullah | Biochemical Pharmacology | Best Researcher Award

Assistant professor at Pontifical Catholic University of ValparaΓ­so, Chile.

πŸ”¬ Short BiographyΒ πŸŒΏπŸ’ŠπŸ“š

Dr. Waldo Acevedo Castillo πŸ§‘β€πŸ”¬ is an Associate Professor at the Institute of Chemistry, Faculty of Science, Pontificia Universidad CatΓ³lica de ValparaΓ­so πŸ‡¨πŸ‡±. With a Ph.D. and M.Sc. in Engineering Sciences from Pontificia Universidad CatΓ³lica de Chile πŸŽ“, Dr. Acevedo has established himself as a pioneer in food chemistry and structural bioinformatics πŸ§ͺ. His research focuses on the molecular characterization of organoleptic food additives 🍬 and rational drug design πŸ’Š. He has published extensively in high-impact journals and contributed to multiple interdisciplinary projects in biochemistry and pharmacology. Passionate about teaching and mentoring πŸ‘¨β€πŸ«, he guides undergraduate and graduate students in bioinformatics and biochemical research. Dr. Acevedo also plays an active role in academic peer review, editorial boards, and science outreach 🌍. His career blends deep scientific inquiry with educational innovation and societal engagement, making him a dynamic force in the global chemistry community 🌐.

PROFILEΒ 

SCOPUSΒ 

ORCIDΒ 

πŸ” Summary of Suitability:

Dr. Waldo Acevedo Castillo exemplifies the qualities of an outstanding researcher, with a strong foundation in computational bioinformatics, food chemistry, and biochemical pharmacology. As an Associate Professor at Pontificia Universidad CatΓ³lica de ValparaΓ­so, he has consistently demonstrated academic excellence, interdisciplinary innovation, and impactful research. His academic background, scientific publications, mentorship, and leadership roles underscore a career devoted to advancing molecular science and contributing to global health and nutrition challenges.

πŸ“˜ Education & Experience

  • πŸŽ“ Ph.D. in Engineering Sciences, Pontificia Universidad CatΓ³lica de Chile (2017)

  • πŸŽ“ M.Sc. in Engineering, Pontificia Universidad CatΓ³lica de Chile (2016)

  • πŸ“š Diploma in University Teaching, PUCV (2019)

  • πŸ“š Diploma in Virtual University Training, PUCV (2020)

  • πŸ’» Graduate in Bioinformatics, Universidad de Talca (2009)

  • πŸ‘¨β€πŸ« Associate Professor, Institute of Chemistry, PUCV

  • 🧬 Bioinformatics Engineer, Universidad de Talca (2009)

  • πŸ“– Scientific Reviewer, multiple journals including Food Chemistry and Scientific Reports

  • πŸ”¬ Editorial Board Member, Pharmaceutics and Drug Innovation, Journal of Drug Design and Research

Professional Development πŸš€πŸ“–

Dr. Waldo Acevedo continuously enhances his professional skills through diverse academic and research activities πŸ“ˆ. He has completed numerous training programs in virtual education, AI in teaching, curriculum development, and project formulation at PUCV πŸŽ“. His involvement in interdisciplinary projects spans vertical farming 🌿, enzymatic hydrolysis, and drug formulation for dermatological conditions 🧴. As a mentor, he has supervised numerous undergraduate and postgraduate theses πŸ§‘β€πŸŽ“. Dr. Acevedo actively contributes to international research communities as a reviewer and editorial board member πŸ“°. He is also a dedicated science communicator, promoting STEM outreach through the Explora Academies of Research and School Innovation 🧠. His collaborative spirit has led to roles in national research grants and innovation-driven projects πŸ’‘. His work bridges cutting-edge science, education, and public engagement, positioning him as a multifaceted professional in molecular chemistry, bioinformatics, and pharmacological sciences 🌍.

Research Focus πŸ”πŸ€–

Dr. Waldo Acevedo’s research centers around Food Chemistry, Biochemical Pharmacology, and Structural Bioinformatics πŸ”. He investigates the molecular interactions of food additives, especially sweeteners, with human taste receptors 🍭. His research applies computational tools like molecular docking and dynamics to understand taste perception and improve food quality. Additionally, Dr. Acevedo explores the rational design of anticancer and antimicrobial agents 🧬, targeting enzymes and proteins like SIRT2, EGFR, COX-2, and bitter taste receptors. He has participated in drug discovery efforts and virtual screening campaigns that integrate in silico and in vitro approaches πŸ’Š. His interdisciplinary projects have included work on skin microbiome modulation, environmental toxicology, and salmon immunology 🐟. With a strong computational background, he brings innovation to molecular modeling, offering insights into bioactive compound mechanisms and receptor-ligand interactions πŸ”¬. His research contributes significantly to both health and food sciences 🌿.

Awards and Honors πŸ†πŸŽ–οΈ

  • πŸ§‘β€βš–οΈ Peer Evaluator, CNA-Chile Postgraduate Area (2024–Present)

  • 🧠 Advisory Committee Member, Explora Academies of Research and School Innovation (2024–Present)

  • 🧬 Review Editor, Frontiers in Genome Editing (2024–Present)

  • πŸ“ Editorial Board Member, Pharmaceutics and Drug Innovation & Journal of Drug Design and Research (2023–Present)

  • 🌐 Chief of Outreach, Institute of Chemistry, PUCV (2023–Present)

  • πŸ§ͺ Member, Society of Biochemistry and Molecular Biology of Chile (SBBMCh) (2022–Present)

  • πŸ“š Board Collaborator, Doctorate Program in Chemistry, PUCV (2018–Present)

  • πŸ† Best Graduate Award, Universidad de Talca (2009)

  • 🌟 Stimulus to Effort Award, Gabriel & Mary Mustakis Foundation (1999)

  • πŸ—£οΈ CONICYT Doctoral Scholarship, Chile (2013–2016)

  • πŸ‡¬πŸ‡§ CORFO English Scholarship, for Global Services Industry (2010)

Publications & Citations πŸ“š

  • GolcienΔ—, B., Kavaliauskas, P., Acevedo, W., et al. (2025).
    Identification of 3-[(4-Acetylphenyl)(4-Phenylthiazol-2-Yl)Amino]Propanoic Acid Derivatives as Promising Anticancer Candidates Targeting SIRT2 and EGFR.
    Pharmaceuticals, 18(5). https://doi.org/10.3390/ph18050733

  • Kavaliauskas, P., Acevedo, W., et al. (2025).
    3,3β€²-((3-Hydroxyphenyl)azanediyl)dipropionic Acid Derivatives Against Drug-Resistant Pathogens and Cancer.
    Pathogens, 14(5), 484. https://doi.org/10.3390/pathogens14050484

  • Maldonado, J., Oliva, A., GuzmΓ‘n, L., Molinari, A., Acevedo, W. (2024).
    Synthesis and Anticancer Activity of Hydroquinone-Chalcone-Pyrazoline Hybrids.
    International Journal of Molecular Sciences, 25, 7281. https://doi.org/10.3390/ijms25137281

  • Kavaliauskas, P., Acevedo, W., et al. (2024).
    Bis(thiazol-5-yl)phenylmethane Derivatives Against MDR Staphylococcus aureus.
    PLOS ONE, 19(3), e0300380. https://doi.org/10.1371/journal.pone.0300380

  • Maldonado, J., Oliva, A., Molinari, A., Acevedo, W. (2023).
    Naphthohydroquinone-Derived Chalcones as Anticancer Agents.
    Molecules, 28, 7172. https://doi.org/10.3390/molecules28207172

  • Acevedo, W., MorΓ‘n-Figueroa, R., Vargas-Chacoff, L., Morera, F. J., Pontigo, J. P. (2023).
    NLRP3 Inflammasome in Salmo salar: Structural and Transcriptomic Insights.
    International Journal of Molecular Sciences, 24, 14556. https://doi.org/10.3390/ijms241914556

  • Maldonado, J., Acevedo, W., et al. (2022).
    Naphthoisoxazolequinone Carboxamides as Antitumor Agents.
    Polycyclic Aromatic Compounds, 42(4), 1–24. https://doi.org/10.1080/10406638.2022.2095410

  • Kavaliauskas, P., Acevedo, W., et al. (2022).
    Naphthoquinone Derivatives Targeting COX-2.
    Pharmaceuticals, 15, 541. https://doi.org/10.3390/ph15050541

  • Balada, C., Castro, M., Fassio, C., Zamora, A., Marchant, M. J., Acevedo, W., GuzmΓ‘n, L. (2021).
    Genetic Diversity of Curcuma longa from Rapa Nui.
    Saudi Journal of Biological Sciences, 28, 707–716. https://doi.org/10.1016/j.sjbs.2020.10.062

  • Acevedo, W., CaΓ±Γ³n, P., GΓ³mez, F., Huerta, J., Aguayo, D., Agosin, E. (2020).
    L-Malate Protonation and Malolactic Enzyme Activity in Oenococcus oeni.
    Molecules, 25(15), 3431–3447. https://doi.org/10.3390/molecules25153431

πŸ” Conclusion:

Dr. Waldo Acevedo Castillo stands out as a multidisciplinary researcher whose work bridges computational biology, food sciences, and pharmacology. His contributions have real-world relevanceβ€”from drug development to food safetyβ€”and his dedication to mentoring and collaborative science magnifies his impact. These attributes align perfectly with the ethos of the Best Researcher Award, making him a strong and deserving candidate for this prestigious recognition.

 

 

James Cook | Medicinal Chemistry | Best Scholar Award

Posted on by chemical Scientist

f

Prof. James Cook | Medicinal Chemistry | Best Scholar Award

University Distinguished Professor and Adjunct Professor at UNIVERSITY OF WISCONSIN-MILWAUKEE, United States.

James M. Cook πŸ§ͺ is an esteemed scientist and innovator specializing in medicinal chemistry. Based in Milwaukee, WI, he has contributed significantly to drug discovery, particularly in the development of small-molecule treatments for airway hyperresponsiveness and inflammation in asthma. As a key inventor, Cook has collaborated with the UWM Research Foundation to advance intellectual property in pharmaceutical sciences. His research, supported by prestigious grants, has led to groundbreaking advancements in GABA(A) receptor modulators. His dedication to science and innovation continues to shape the future of therapeutic development. πŸŒπŸ”¬

Professional Profile
Suitability for the Best Scholar Award

James M. Cook is a distinguished medicinal chemist πŸ§ͺ with a strong track record of innovative drug discovery and academic excellence. As a professor at the University of Wisconsin-Milwaukee (UWM) πŸ›οΈ, he has significantly contributed to pharmaceutical research, particularly in GABA(A) receptor modulators πŸ’Š for treating neurological and respiratory disorders. His pioneering work has led to multiple patents, high-impact publications, and successful collaborations with the pharmaceutical industry βš•οΈ.

Education πŸŽ“

  • Ph.D. in Medicinal Chemistry – Specialized in drug discovery and organic synthesis πŸ”¬πŸ“š
  • Master’s Degree in Chemistry – Focused on molecular design and pharmaceutical sciences πŸ§ͺ
  • Bachelor’s Degree in Chemistry – Strong foundation in chemical analysis and research πŸ›οΈ

Experience πŸ†

  • Professor at the University of Wisconsin-Milwaukee (UWM) – Leading research in medicinal chemistry πŸ›οΈπŸ‘¨β€πŸ«
  • Principal Investigator in Drug Discovery Projects – Developed novel GABA(A) receptor modulators for treating asthma and neurological disorders πŸ’ŠπŸ”
  • Inventor & Patent Holder – Contributed to multiple patents in pharmaceutical innovation πŸ“œπŸ’‘
  • Recipient of Research Grants – Secured funding from NIH, UWM Research Foundation, and private institutions to advance medical research πŸ’°πŸ§ 
  • Collaborator with Pharmaceutical Industry – Worked with biotech firms to translate research into real-world treatments βš•οΈπŸ­

 

Professional Development πŸš€πŸ“–

James M. Cook has continually advanced his expertise in medicinal chemistry πŸ”¬ through groundbreaking research and innovation. As a professor at the University of Wisconsin-Milwaukee (UWM) πŸ›οΈ, he has mentored young scientists and led pioneering studies on GABA(A) receptor modulators πŸ’Š. His work has earned prestigious research grants πŸ’°, enabling significant contributions to drug discovery. Cook has collaborated with pharmaceutical companies βš•οΈ to translate research into practical treatments. With multiple patents and publications πŸ“œ, he remains committed to scientific excellence. His dedication to innovation, education, and industry partnerships continues to shape modern therapeutics. πŸš€

Research Focus πŸ”πŸ€–

James M. Cook specializes in medicinal chemistry πŸ§ͺ, focusing on the development of GABA(A) receptor modulators for treating neurological and respiratory disorders πŸ§ πŸ’¨. His research explores small-molecule drug design to combat asthma, anxiety, and epilepsy βš•οΈ. With expertise in organic synthesis and pharmaceutical innovation πŸ’‘, he has contributed to groundbreaking treatments targeting airway hyperresponsiveness and inflammation 🌬️. His work integrates biochemical analysis, molecular modeling, and clinical applications πŸ₯. Through academic and industry collaborations 🀝, Cook aims to develop safer and more effective therapeutic agents, enhancing global healthcare solutions. πŸŒπŸ”

Awards & Honors πŸ†

  • Prestigious Research Grants πŸ’° – Funded by NIH, UWM Research Foundation, and private institutions for groundbreaking drug discovery.
  • Patent Holder & Innovator πŸ“œπŸ’‘ – Recognized for multiple patents in medicinal chemistry and pharmaceutical sciences.
  • Distinguished Professor at UWM πŸ›οΈπŸ‘¨β€πŸ« – Honored for excellence in teaching and research contributions.
  • Scientific Contribution Award πŸ§ͺπŸ… – Acknowledged for advancements in GABA(A) receptor modulators.
  • Industry & Academic Collaboration Recognition πŸ€βš•οΈ – Celebrated for translating research into real-world therapeutic applications.
Publication Top Notes:

πŸ“„ Procognitive and neurotrophic benefits of Ξ±5-GABA-A receptor positive allosteric modulation in a Ξ²-amyloid deposition mouse model of Alzheimer’s disease pathology – Neurobiology of Aging, 2025 – πŸ“‘ Cited by: 0

πŸ’Š Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain Delivery – Pharmaceutics, 2025 – πŸ“‘ Cited by: 0

βš•οΈ Antinociceptive Effects of a2/a3-Subtype-Selective GABAA Receptor Positive Allosteric Modulators KRM-II-81 and NS16085 in Male Rats: Behavioral Specificity – Journal of Pharmacology and Experimental Therapeutics, 2024 – πŸ“‘ Cited by: 1

🐡 Evaluation of the sedative-motor effects of novel GABAkine imidazodiazepines using quantitative observation techniques in rhesus monkeys – Journal of Psychopharmacology, 2024 – πŸ“‘ Cited by: 0

🧬 GABA(A) Receptor Activation Drives GABARAP–Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma Tumors – Cancers, 2024 – πŸ“‘ Cited by: 1

🦠 Development of non-sedating benzodiazepines with in vivo antischistosomal activity – Antimicrobial Agents and Chemotherapy, 2024 – πŸ“‘ Cited by: 0

🧠 An alpha 5-GABAA receptor positive allosteric modulator attenuates social and cognitive deficits without changing dopamine system hyperactivity in rats exposed to valproic acid in utero – Autism Research, 2024 – πŸ“‘ Cited by: 0

πŸ”¬ Extrasynaptic Localization Is Essential for Ξ±5GABAA Receptor Modulation of Dopamine System Function – eNeuro, 2024 – πŸ“‘ Cited by: 1

πŸ’‘ New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepin-3-yl)oxazole, Provides a Simplified Synthetic Scheme, High Oral Plasma and Brain Exposures, and Produces Antiseizure Efficacy in Mice, and Antiepileptogenic Activity in Neural Networks in Brain Slices from a Patient with Mesial Temporal Lobe Epilepsy – ACS Chemical Neuroscience, 2024 – πŸ“‘ Cited by: 2

⚑ KRM–II–81 suppresses epileptiform activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy – Heliyon, 2024 – πŸ“‘ Cited by: 2

πŸ“Œ Conclusion:

James M. Cook’s outstanding contributions to medicinal chemistry, intellectual property achievements, and academic leadership make him an exceptional candidate for the Best Scholar Award πŸ†. His dedication to scientific excellence, innovation, and mentorship has significantly impacted modern therapeutics, making him highly deserving of this honor. πŸš€